NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

TaiMed Biologics Inc (TWO: 4147)

 
4147 Technical Analysis
1
As on 9th Jun 2023 4147 STOCK Price closed @ 105.50 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4147STOCK Price

Open 107.50 Change Price %
High 108.50 1 Day N/A N/A
Low 105.00 1 Week 0.00 0.00
Close 105.50 1 Month 0.00 0.00
Volume 1359028 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
TWO Taiwan Most Active Stocks
6125 44.70 %
4533 18.00 %
4979 76.40 %
6122 44.45 %
5425 102.00 %
8358 63.30 %
3374 128.00 %
2743 162.50 %
8069 227.00 %
1815 13.95 %
 
TWO Taiwan Top Gainers Stocks
5306 172.00 3.30%
8438 38.40 1.99%
1752 39.55 0.25%
1752 39.55 0.25%
 
TWO Taiwan Top Losers Stocks
3652 22.55 -0.88%
 
 
4147
Daily Charts
4147
Intraday Charts
Whats New @
Bazaartrend
4147
Free Analysis
 
4147 Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
4147 Forecast September 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
4147 Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
4147 Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
TaiMed Biologics Inc ( TWO Taiwan Symbol : 4147 )
Sector : Healthcare And Other Stocks in Same Sector
 
4147 Other Details
Segment EQ
Market Capital 17560358912.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4147 Address
4147
 
4147 Latest News
 
Your Comments and Response on TaiMed Biologics Inc
 
4147 Business Profile
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody that is in Phase II clinical trials for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase II clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which is in Phase I clinical trials for treating HIV infections; TMB-370, a bispecific neutralizing antibody that is in Phase I clinical trials to treat HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was founded in 2007 and is headquartered in Taipei, Taiwan. Address: No. 607, Ruiguang Road, Taipei, Taiwan, 11492
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service